je.st
news
Tag: clinical
Merck Enters Agreement with Bristol-Myers Squibb to Conduct a Phase II Clinical Trial Evaluating Combination of Investigational Oral Candidates MK-5172 and Daclatasvir for Chronic Hepatitis C
2013-04-22 13:30:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK) today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb to conduct a Phase II clinical trial to evaluate the safety and efficacy of a once-daily oral combination regimen consisting of Bristol-Myers Squibbs investigational NS5A replication complex inhibitor daclatasvir and Merck's investigational NS3/4A protease inhibitor MK-5172 for the treatment of chronic hepatitis C virus (HCV) infection, genotype 1. Language: English Contact HTML: MerckMedia:Caroline Lappetito, (267) 305-7639orInvestor:Carol Ferguson, (908) 423-4465Justin Holko, (908) 423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: c
agreement
trial
combination
Aspect Imaging Announces FDA Clearance of M2(TM) Compact MRI System for Clinical Imaging of ...
2013-04-19 06:00:00| Industrial Newsroom - All News for Today
Clinical studies on point-of-care wrist imaging planned at UCLA<br /> <br /> Using this novel compact MRI platform<br /> <br /> SALT LAKE CITY, UT – Aspect Imaging, the world leading developer of compact high-performance magnets, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's M2™ compact MRI system for diagnostic imaging of the wrist.<br /> <br /> The system is a novel compact, high-performance MRI instrument for rapid, just-in-place ...This story is related to the following:Green & CleanMedical Imaging Systems | Mobile Magnetic Resonance Imaging (MRI) Units |
Tags: of
system
clinical
aspect
Clinical Pathology
2013-04-07 15:11:47| drugdiscoveryonline News Articles
Clinical Bioanalytical Analysis
2013-04-07 15:11:07| drugdiscoveryonline News Articles
Tags: analysis
clinical
bioanalytical
clinical analysis
"ISPE Releases New Guidance for Standardizing Use of Booklet Labels in Global Clinical ...
2013-04-03 06:00:00| Industrial Newsroom - All News for Today
ISPE has issued first-ever guidance to help companies conducting clinical trials in multiple countries standardize their use of booklet labels. Templates, guidelines, and tools make it easier for companies to use booklet labels consistently and effectively and justify their booklet label methods to international regulatory authorities. By following recommendations, companies can feel confident that their booklet label strategy is supported by scientific, risk-based methodology. This story is related to the following:Trade Associations
Tags: global
releases
clinical
labels
Sites : [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] next »